• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

即使将适应症扩大到超过传统的4厘米界限,保留肾单位手术在保护肾功能方面也优于根治性肾切除术。

Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.

作者信息

Pignot Géraldine, Bigot Pierre, Bernhard Jean-Christophe, Bouliere Fabien, Bessede Thomas, Bensalah Karim, Salomon Laurent, Mottet Nicolas, Bellec Laurent, Soulié Michel, Ferrière Jean-Marie, Pfister Christian, Drai Julien, Colombel Marc, Villers Arnauld, Rigaud Jerome, Bouchot Olivier, Montorsi Francesco, Bertini Roberto, Belldegrun Arie S, Pantuck Allan J, Patard Jean-Jacques

机构信息

Department of Urology, Bicetre Hospital, Paris XI University, Le Kremlin Bicêtre, France.

Department of Urology, Angers University Hospital, Angers, France.

出版信息

Urol Oncol. 2014 Oct;32(7):1024-30. doi: 10.1016/j.urolonc.2014.03.012. Epub 2014 Jul 2.

DOI:10.1016/j.urolonc.2014.03.012
PMID:24996775
Abstract

OBJECTIVES

To analyze to what extent partial nephrectomy (PN) is superior to radical nephrectomy (RN) in preserving renal function outcome in relation to tumor size indication.

METHODS AND MATERIALS

Clinical data from 973 patients operated at 9 academic institutions were retrospectively analyzed. Glomerular filtration rate (GFR) before and after surgery was calculated with the abbreviated Modification of the Diet in Renal Disease equation. For a fair comparison between the 2 techniques, all imperative indications for PN were excluded. A shift to a less favorable GFR group following surgery was considered clinically significant.

RESULTS

Median age at diagnosis was 60 years (19-91). Tumor size was smaller than 4 cm in 665 (68.3%) cases and larger than 4 cm in 308 (31.7%) cases. PN and RN were performed in 663 (68.1%) and 310 (31.9%) patients, respectively. In univariate analysis, patients undergoing PN had a smaller risk for developing significant GFR change following surgery than those undergoing RN did. This was true for tumors≤4 cm (P = 0.0001) and for tumors>4 cm (P = 0.0001). In multivariate analysis, the following criteria were independent predictive factors for developing significant postoperative GFR loss: the use of RN (P = 0.0001), preoperative GFR<60 ml/min (P = 0.0001), tumor size≥4 cm (P = 0.0001), and older age at diagnosis (P = 0.0001).

CONCLUSIONS

The renal function benefit carried out by elective PN over RN persists even when expanding nephron-sparing surgery indications beyond the traditional 4-cm cutoff.

摘要

目的

分析在肿瘤大小指征方面,部分肾切除术(PN)在保留肾功能结局上优于根治性肾切除术(RN)的程度。

方法与材料

回顾性分析来自9家学术机构的973例接受手术患者的临床资料。采用简化的肾脏疾病饮食改良方程计算手术前后的肾小球滤过率(GFR)。为了对这两种技术进行公平比较,排除了所有PN的必要指征。术后向较差GFR组的转变被认为具有临床意义。

结果

诊断时的中位年龄为60岁(19 - 91岁)。665例(68.3%)患者的肿瘤大小小于4 cm,308例(31.7%)患者的肿瘤大小大于4 cm。分别有663例(68.1%)和310例(31.9%)患者接受了PN和RN。在单因素分析中,接受PN的患者术后发生显著GFR变化的风险低于接受RN的患者。对于肿瘤≤4 cm(P = 0.0001)和肿瘤>4 cm(P = 0.0001)的情况均如此。在多因素分析中,以下标准是术后发生显著GFR损失的独立预测因素:使用RN(P = 0.0001)、术前GFR<60 ml/min(P = 0.0001)、肿瘤大小≥4 cm(P = 0.0001)以及诊断时年龄较大(P = 0.0001)。

结论

即使将保肾手术指征扩大到传统的4 cm临界值以上,选择性PN相对于RN在肾功能方面的益处仍然存在。

相似文献

1
Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.即使将适应症扩大到超过传统的4厘米界限,保留肾单位手术在保护肾功能方面也优于根治性肾切除术。
Urol Oncol. 2014 Oct;32(7):1024-30. doi: 10.1016/j.urolonc.2014.03.012. Epub 2014 Jul 2.
2
[Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].对于大于4厘米的肿瘤,保留肾单位手术在保留肾功能结果方面优于根治性肾切除术。
Prog Urol. 2011 Nov;21(12):842-50. doi: 10.1016/j.purol.2011.05.005. Epub 2011 Jul 16.
3
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.部分和根治性肾切除术治疗良性肾肿瘤患者的 IV 期慢性肾脏病的总生存和发展。
Eur Urol. 2013 Oct;64(4):600-6. doi: 10.1016/j.eururo.2012.12.023. Epub 2012 Dec 25.
4
Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy?与根治性肾切除术相比,部分肾切除术能否保留肾功能并改善生存率?
Scand J Urol Nephrol. 2011 Mar;45(2):143-50. doi: 10.3109/00365599.2010.548082. Epub 2011 Jan 19.
5
Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm.功能性分析:选择性保肾手术与根治性肾切除术治疗大于 4 厘米的肾肿瘤。
Urology. 2012 Mar;79(3):607-13. doi: 10.1016/j.urology.2011.10.073.
6
Impact of renal surgery for cortical neoplasms on lipid metabolism.肾皮质肿瘤手术对脂代谢的影响。
BJU Int. 2014 Dec;114(6):837-43. doi: 10.1111/bju.12744. Epub 2014 Jul 15.
7
Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors.小肾肿瘤患者根治性手术后慢性肾脏病的预后因素
Urology. 2009 Nov;74(5):1064-8. doi: 10.1016/j.urology.2009.05.090. Epub 2009 Sep 16.
8
Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.老年T1-T2期肾肿瘤行部分肾切除术与根治性肾切除术的比较:并发症、肾功能及肿瘤学结局分析
Urology. 2017 Feb;100:151-157. doi: 10.1016/j.urology.2016.10.047. Epub 2016 Nov 23.
9
Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.与根治性肾切除术相比,保留肾单位手术为年龄在20至44岁之间、患有肾细胞癌(≤4厘米)的患者提供了长期生存优势:一项监测、流行病学和最终结果(SEER)数据库分析。
Urol Oncol. 2014 Jul;32(5):549-54. doi: 10.1016/j.urolonc.2013.11.009. Epub 2014 Feb 2.
10
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.保留肾单位手术治疗直径大于 7cm 的肾肿瘤:发病率、肾功能和肿瘤学结局。
Clin Genitourin Cancer. 2014 Feb;12(1):e19-27. doi: 10.1016/j.clgc.2013.09.004. Epub 2013 Sep 28.

引用本文的文献

1
Partial nephrectomy versus radiofrequency ablation in patients with cT1a renal cell carcinoma: A surveillance, epidemiology, end results (SEER) analysis.部分肾切除术与射频消融术治疗 cT1a 期肾细胞癌患者的比较:监测、流行病学和最终结果(SEER)分析。
Medicine (Baltimore). 2024 Nov 29;103(48):e40721. doi: 10.1097/MD.0000000000040721.
2
A Modified Two-Layer Suture Technique for Transperitoneal Laparoscopic Partial Nephrectomy: Single-Center Clinical Experience.一种改良的两层缝合技术用于经腹腔腹腔镜部分肾切除术:单中心临床经验
Front Surg. 2022 Feb 1;8:761090. doi: 10.3389/fsurg.2021.761090. eCollection 2021.
3
Predictive models for chronic kidney disease after radical or partial nephrectomy in renal cell cancer using early postoperative serum creatinine levels.
利用术后早期血清肌酐水平建立的肾细胞癌根治性或部分肾切除术后慢性肾脏病预测模型。
J Transl Med. 2021 Jul 16;19(1):307. doi: 10.1186/s12967-021-02976-2.
4
The role of three-dimensional reconstruction in laparoscopic partial nephrectomy for complex renal tumors.三维重建在腹腔镜肾部分切除术治疗复杂肾肿瘤中的作用。
World J Surg Oncol. 2019 Sep 11;17(1):159. doi: 10.1186/s12957-019-1701-x.
5
Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.4 cm 至 7 cm 肾细胞癌行部分切除术与根治性切除术的长期随访和围手术期结局比较:系统评价和荟萃分析。
BMC Urol. 2019 Jun 7;19(1):48. doi: 10.1186/s12894-019-0480-6.
6
Comparison of overall survival and unplanned hospital readmissions between partial and radical nephrectomy for cT1a and cT1b renal masses.cT1a和cT1b期肾肿块行部分肾切除术与根治性肾切除术的总生存率及非计划住院再入院情况比较。
Ther Adv Urol. 2018 Nov 9;10(12):383-391. doi: 10.1177/1756287218810313. eCollection 2018 Dec.
7
Nephron Sparing Surgery Has Better Oncologic Outcomes Than Extirpative Nephrectomy in T1a but Not in T1b or T2 Stage Renal Cell Carcinoma.在T1a期肾细胞癌中,保留肾单位手术比根治性肾切除术具有更好的肿瘤学结局,但在T1b期或T2期则不然。
Med Sci Monit. 2017 Jul 18;23:3480-3488. doi: 10.12659/msm.903563.
8
Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.小肾癌经皮射频消融的临床疗效
Oncol Lett. 2017 Jul;14(1):918-924. doi: 10.3892/ol.2017.6262. Epub 2017 May 26.
9
Renal cell carcinoma.肾细胞癌。
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.